05-23-0300 Atrial Natriuretic Factor 1-28, Human - CAS 91917-63-4 - Calbiochem

05-23-0300
価格が見つかりません
Minimum Quantity needs to be mulitiple of
弊社照会 詳細を表示 
値引
()
 
弊社照会
現在国内在庫なし現在国内在庫なし
現在国内在庫有り 
販売中止
在庫僅少
現在国内在庫あり
    Remaining : Will advise
      Remaining : Will advise
      注文対象外
      お問合せください
      Contact Customer Service
      価格&在庫状況を照会
      クリックして印刷用に表示

      概要

      Replacement Information

      主要スペック表

      Empirical FormulaCAS #
      C₁₂₇H₂₀₃N₄₅O₃₉S₃ 91917-63-4

      価格&在庫状況

      カタログ番号在庫状況 包装 Qty/Pk 価格 数量
      05-23-0300-0.5MGCN
      在庫状況検索中…
      現在国内在庫なし現在国内在庫なし
      現在国内在庫有り 
      販売中止
      在庫僅少
      現在国内在庫あり
        Remaining : Will advise
          Remaining : Will advise
          注文対象外
          お問合せください
          Contact Customer Service

          樹脂アンプル .5 mg
          価格を検索中…
          価格が見つかりません
          Minimum Quantity needs to be mulitiple of
          弊社照会 詳細を表示 
          値引
          ()
           
          弊社照会
          05-23-0300-1MGCN
          在庫状況検索中…
          現在国内在庫なし現在国内在庫なし
          現在国内在庫有り 
          販売中止
          在庫僅少
          現在国内在庫あり
            Remaining : Will advise
              Remaining : Will advise
              注文対象外
              お問合せください
              Contact Customer Service

              樹脂アンプル 1 mg
              価格を検索中…
              価格が見つかりません
              Minimum Quantity needs to be mulitiple of
              弊社照会 詳細を表示 
              値引
              ()
               
              弊社照会
              Description
              OverviewIncreases the rate of renal excretion. Higher levels are reported in congestive heart failure. Inhibits MAP kinase through the natriuretic peptide clearance receptor.
              Catalogue Number05-23-0300
              Brand Family Calbiochem®
              SynonymshANF, ANP, SLRRSSCFGGRMDRIGAQSGLGCNSFRY
              References
              ReferencesPrins, B.A., et al. 1996. J. Biol. Chem. 271, 14156.
              Yechieli, H., et al. 1993. Am. J. Physiol. 265, F119.
              Product Information
              CAS number91917-63-4
              ATP CompetitiveN
              FormWhite to off-white lyophilized solid
              FormulationSupplied as a trifluoroacetate salt.
              Hill FormulaC₁₂₇H₂₀₃N₄₅O₃₉S₃
              Chemical formulaC₁₂₇H₂₀₃N₄₅O₃₉S₃
              Hygroscopic Hygroscopic
              ReversibleN
              Sold on the basis of peptide contentY
              Applications
              Biological Information
              Primary TargetIncreases the rate of renal excretion
              Purity≥97% by HPLC
              Physicochemical Information
              Cell permeableN
              Peptide ContentY
              Peptide SequenceH-Ser-Leu-Arg-Arg-Ser-Ser-Cys⁷-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys²³-Asn-Ser-Phe-Arg-Tyr-OH (disulfide bond: 7 → 23)
              Dimensions
              Materials Information
              Toxicological Information
              Safety Information according to GHS
              Safety Information
              Product Usage Statements
              Storage and Shipping Information
              Ship Code Ambient Temperature Only
              Toxicity Standard Handling
              Storage -20°C
              Hygroscopic Hygroscopic
              Do not freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
              Packaging Information
              Transport Information
              Supplemental Information
              Specifications

              Documentation

              Atrial Natriuretic Factor 1-28, Human - CAS 91917-63-4 - Calbiochem (M)SDS

              タイトル

              英語版製品安全データシート((M)SDS) 

              Atrial Natriuretic Factor 1-28, Human - CAS 91917-63-4 - Calbiochem 試験成績書(CoA)

              タイトルロット番号
              05-23-0300

              参考資料

              参考資料の概要
              Prins, B.A., et al. 1996. J. Biol. Chem. 271, 14156.
              Yechieli, H., et al. 1993. Am. J. Physiol. 265, F119.
              データシート

              Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

              Revision18-September-2008 RFH
              SynonymshANF, ANP, SLRRSSCFGGRMDRIGAQSGLGCNSFRY
              DescriptionIncreases the rate of renal excretion. Higher levels are reported in congestive heart failure. Inhibits MAP kinase through the clearance receptor.
              FormWhite to off-white lyophilized solid
              FormulationSupplied as a trifluoroacetate salt.
              CAS number91917-63-4
              Chemical formulaC₁₂₇H₂₀₃N₄₅O₃₉S₃
              Peptide SequenceH-Ser-Leu-Arg-Arg-Ser-Ser-Cys⁷-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys²³-Asn-Ser-Phe-Arg-Tyr-OH (disulfide bond: 7 → 23)
              Purity≥97% by HPLC
              Solubility5% acetic acid (1 mg/ml)
              Storage -20°C
              Hygroscopic
              Do Not Freeze Ok to freeze
              Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 1 month at -20°C.
              Toxicity Standard Handling
              Merck USA index14 1360
              ReferencesPrins, B.A., et al. 1996. J. Biol. Chem. 271, 14156.
              Yechieli, H., et al. 1993. Am. J. Physiol. 265, F119.